Seasonal occurrence, removal, mass loading and environmental risk assessment of 55 pharmaceuticals and personal care products in a municipal wastewater treatment plant in Central Greece

Science of the Total Environment

Volumn 543, Issue , 2016, Pages 547-569

  Papageorgiou, Myrsini ^a   Kosma, Christina ^b   Lambropoulou, Dimitra ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Environmental risk assessment; Mass loading; Occurrence; PPCPs; Wastewaters

Indexed keywords

ANTIBIOTICS; CHROMATOGRAPHY; DRUG PRODUCTS; EFFLUENTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHASE SEPARATION; RISK ASSESSMENT; SALICYLIC ACID; SEWAGE PUMPING PLANTS; TOXICITY; WASTEWATER; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

ENVIRONMENTAL RISK ASSESSMENT; LIQUID CHROMATOGRAPHY COUPLED WITH TANDEM MASS SPECTROMETRIES; MASS LOADINGS; MUNICIPAL WASTEWATER TREATMENT PLANTS; OCCURRENCE; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; PPCPS; WASTEWATER TREATMENT PLANTS;

LOADING;

ACETYLSALICYLIC ACID; AMPICILLIN; ATENOLOL; CAFFEINE; CARBAMAZEPINE; CETIRIZINE; CIPROFLOXACIN; DICLOFENAC; FLUVOXAMINE; FUROSEMIDE; INDOMETACIN; KETOPROFEN; LINCOMYCIN; METOPROLOL; METRONIDAZOLE; MOXIFLOXACIN; NAPROXEN; NIMESULIDE; PARACETAMOL; PHENAZONE; PIROXICAM; PROPANOL; SALICYLIC ACID; SILDENAFIL; SIMVASTATIN; SULFAMETHOXAZOLE; TRIMETHOPRIM; VENLAFAXINE; COSMETIC; DRUG; WASTE WATER; WATER POLLUTANT;

CHEMICAL POLLUTANT; CONCENTRATION (COMPOSITION); DRUG; EFFLUENT; ENVIRONMENTAL RISK; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLLUTANT REMOVAL; RISK ASSESSMENT; TOXICITY; WASTEWATER;

ALGA; ARTICLE; AUTUMN; CONCENTRATION (PARAMETERS); ECOTOXICOLOGY; EFFLUENT; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL MONITORING; ENVIRONMENTAL PARAMETERS; ENVIRONMENTAL SANITATION; FISH; GREECE; INVERTEBRATE; LIQUID CHROMATOGRAPHY; MASS LOADING; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEASONAL VARIATION; SOLID PHASE EXTRACTION; SUMMER; TANDEM MASS SPECTROMETRY; TOXICITY TESTING; WASTE COMPONENT REMOVAL; WASTE WATER TREATMENT PLANT; WATER POLLUTANT; WINTER; ANALYSIS; CHEMISTRY; RISK ASSESSMENT; SEASON; SEWAGE; STATISTICS AND NUMERICAL DATA; WASTE WATER;

GREECE;

COSMETICS; ENVIRONMENTAL MONITORING; GREECE; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; SEASONS; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84947716804     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.11.047     Document Type: Article

References (115)

1. Acuna V., von Schiller D., Garcia-Galan M.J., Rodriguez-Mozaz S., Corominas L., Petrovic M., et al. Occurrence and in-stream attenuation of wastewater-derived pharmaceuticals in Iberian rivers. Sci. Total Environ. 2015, 503-504:133-141.
2. Al Aukidy M., Verlicchi P., Jelic A., Petrovic M., Barcelo D. Monitoring release of pharmaceutical compounds: occurrence and environmental risk assessment of two WWTP effluents and their receiving bodies in the Po Valley, Italy. Sci. Total Environ. 2012, 438:15-25.
3. Al-Odaini N.A., Zakaria M.P., Yaziz M.I., Surif S., Abdulghani M. The occurrence of human pharmaceuticals in wastewater effluents and surface water of Langat River and its tributaries, Malaysia. Int. J. Environ. Anal. Chem. 2013, 93:245-264.
4. Bahlmann A., Carvalho J.J., Weller M.G., Panne U., Schneider R.J. Immunoassays as high-throughput tools: monitoring spatial and temporal variations of carbamazepine, caffeine and cetirizine in surface and wastewaters. Chemosphere 2012, 89:1278-1286.
5. Bahlmann A., Brack W., Schneider R.J., Krauss M. Carbamazepine and its metabolites in wastewater: analytical pitfalls and occurrence in Germany and Portugal. Water Res. 2014, 57:104-114.
6. Baker D.R., Kasprzyk-Hordern B. Multi-residue analysis of drugs of abuse in wastewater and surface water by solid-phase extraction and liquid chromatography-positive electrospray ionisation tandem mass spectrometry. J. Chromatogr. A 2011, 1218:1620-1631.
7. Bendz D., Paxeus N.A., Ginn T.R., Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Hoje River in Sweden. J. Hazard. Mater. 2005, 122:195-204.
8. Blair B.D., Crago J.P., Hedman C.J., Klaper R.D. Pharmaceuticals and personal care products found in the Great Lakes above concentrations of environmental concern. Chemosphere 2013, 93:2116-2123.
9. Borova V., Maragou N., Gago-Ferrero P., Pistos C., thomaidis . Highly sensitive determination of 68 psychoactive pharmaceuticals, illicit drugs, and related human metabolites in wastewater by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 2014, 406:4273-4285.
10. Calamari D., Zuccato E., Castiglioni S., Bagnati R., Fanelli R. Strategic survey of therapeutic drugs in the Rivers Po and Lambro in Northern Italy. Environ. Sci. Technol. 2003, 37:1241-1248.
11. Carlsson C., Johansson A.K., Alvan G., Bergman K., Kuhler T. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. Sci. Total Environ. 2006, 364:67-87.
12. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40:357-363.
13. Cerqueira M.B., Guilherme J.R., Caldas S.S., Martins M.L., Zanella R., Primel E.G. Evaluation of the QuEChERS method for the extraction of pharmaceuticals and personal care products from drinking-water treatment sludge with determination by UPLC-ESI-MS/MS. Chemosphere 2014, 107:74-82.
14. Choi K., Kim Y., Park J., Park C.K., Kim M., Kim H.S., et al. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. Sci. Total Environ. 2008, 405:120-128.
15. Clara M., Strenn B., Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res. 2004, 38:947-954.
16. Cruz-Morato C., Lucas D., Llorca M., Rodriguez-Mozaz S., Gorga M., Petrovic M., et al. Hospital wastewater treatment by fungal bioreactor: removal efficiency for pharmaceuticals and endocrine disruptor compounds. Sci. Total Environ. 2014, 493:365-376.
17. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107:907-938.
18. Del Rosario K.L., Mitra S., Humphrey C.P., O'Driscoll M.A. Detection of pharmaceuticals and other personal care products in groundwater beneath and adjacent to onsite wastewater treatment systems in a coastal plain shallow aquifer. Sci. Total Environ. 2014, 487:216-223.
19. Díaz-Cruz S., Barceló D. Occurrence and analysis of selected pharmaceuticals and metabolites as contaminants present in waste waters, sludge and sediments. Series Anthropogenic Compounds. 5I1 2004, 227-260. Springer, Berlin Heidelberg. D. Barceló (Ed.).
20. EMEA Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use, London 2006.
21. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res. 2011, 45:75-92.
22. European Commission (EC) Technical guidance document in support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances and Commission Regulation (EC). No 1488/94 on risk assessment for existing substances. Part II, Brussels,Belgium 2003.
23. European Commission Decision (ECD) (2002/657/EC) of 12 August 2002 implementing council directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off. J. Eur. Communities 2002, L221:8-36. (Brussels, Belgium).
24. Evgenidou E.N., Konstantinou I.K., Lambropoulou D.A. Occurrence and removal of transformation products of PPCPs and illicit drugs in wastewaters: a review. Sci. Total Environ. 2015, 505:905-926.
25. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
26. Ferrari B., Mons R., Vollat B., Fraysse B., Paxaus N., Giudice R.L., et al. Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment?. Environ. Toxicol. Chem. 2004, 23:1344-1354.
27. Göbel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ. Sci. Technol. 2005, 39:3981-3989.
28. Golovko O., Kumar V., Fedorova G., Randak T., Grabic R. Seasonal changes in antibiotics, antidepressants/psychiatric drugs, antihistamines and lipid regulators in a wastewater treatment plant. Chemosphere 2014, 111:418-426.
29. Gracia-Lor E., Sancho J.V., Hernandez F. Multi-class determination of around 50 pharmaceuticals, including 26 antibiotics, in environmental and wastewater samples by ultra-high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2011, 1218:2264-2275.
30. Gracia-Lor E., Sancho J.V., Serrano R., Hernandez F. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia. Chemosphere 2012, 87:453-462.
31. Gros M., Petrovic M., Barcelo D. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70:678-690.
32. Gros M., Petrović M., Barceló D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal. Chem. 2009, 81:898-912.
33. Gros M., Petrović M., Barceló D. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (Northeast Spain). Environ. Toxicol. Chem. 2007, 26:1553-1562.
34. Gros M., Petrovic M., Ginebreda A., Barcelo D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 2010, 36:15-26.
35. Gros M., Rodriguez-Mozaz S., Barcelo D. Fast and comprehensive multi-residue analysis of a broad range of human and veterinary pharmaceuticals and some of their metabolites in surface and treated waters by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J. Chromatogr. A 2012, 1248:104-121.
36. Gros M., Rodriguez-Mozaz S., Barcelo D. Rapid analysis of multiclass antibiotic residues and some of their metabolites in hospital, urban wastewater and river water by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J. Chromatogr. A 2013, 1292:173-188.
37. Guerra P., Kim M., Shah A., Alaee M., Smyth S.A. Occurrence and fate of antibiotic, analgesic/anti-inflammatory, and antifungal compounds in five wastewater treatment processes. Sci. Total Environ. 2014, 473-474:235-243.
38. Hansch C., Leo A. Exploring QSAR 1995, American Chemical Society, Washington.
39. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
40. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol. 2002, 266:175-189.
41. Heberer T., Fuhrmann B., Schmidt-Baumler K., Tsipi D., Koutsouba V., Hiskia A. Occurrence of Pharmaceutical Residues in Sewage, River, Ground, and Drinking Water in Greece and Berlin (Germany) 2001, 791:70-83.
42. Hedgespeth M.L., Sapozhnikova Y., Pennington P., Clum A., Fairey A., Wirth E. Pharmaceuticals and personal care products (PPCPs) in treated wastewater discharges into Charleston Harbor, South Carolina. Sci. Total Environ. 2012, 437:1-9.
43. Hernando M.D., Mezcua M., Fernandez-Alba A.R., Barcelo D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
44. Hirsch R., Ternes T., Haberer K., Kratz K.-L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 1999, 225:109-118.
45. Howard P.H., Muir D.C. Identifying new persistent and bioaccumulative organics among chemicals in commerce II: pharmaceuticals. Environ. Sci. Technol. 2011, 45:6938-6946.
46. Hua W.Y., Bennett E.R., Maio X.S., Metcalfe C.D., Letcher R.J. Seasonality effects on pharmaceuticals and s-triazine herbicides in wastewater effluent and surface water from the Canadian side of the upper Detroit river. Environ. Toxicol. Chem. 2006, 25:2356-2365.
47. Huerta B., Jakimska A., Llorca M., Ruhi A., Margoutidis G., Acuna V., et al. Development of an extraction and purification method for the determination of multi-class pharmaceuticals and endocrine disruptors in freshwater invertebrates. Talanta 2015, 132:373-381.
48. Huerta-Fontela M., Galceran M.T., Ventura F. Fast liquid chromatography-quadrupole-linear ion trap mass spectrometry for the analysis of pharmaceuticals and hormones in water resources. J. Chromatogr. A 2010, 1217:4212-4222.
49. Jelic A., Gros M., Ginebreda A., Cespedes-Sánchez R., Ventura F., Petrovic M., et al. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res. 2011, 45:1165-1176.
50. Jelic A., Rodriguez-Mozaz S., Barcelo D., Gutierrez O. Impact of in-sewer transformation on 43 pharmaceuticals in a pressurized sewer under anaerobic conditions. Water Res. 2014, 68C:98-108.
51. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. Multiresidue methods for the analysis of pharmaceuticals, personal care products and illicit drugs in surface water and wastewater by solid-phase extraction and ultra performance liquid chromatography-electrospray tandem mass spectrometry. Anal. Bioanal. Chem. 2008, 391:1293-1308.
52. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res. 2009, 43:363-380.
53. Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res. 2007, 41:1013-1021.
54. Kosma C.I., Lambropoulou D.A., Albanis T.A. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J. Hazard. Mater. 2010, 179:804-817.
55. Kosma C.I., Lambropoulou D.A., Albanis T.A. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment. Sci. Total Environ. 2014, 466-467:421-438.
56. Kosma C.I., Lambropoulou D.A., Albanis T.A. Comprehensive study of the antidiabetic drug metformin and its transformation product guanylurea in Greek wastewaters. Water Res. 2015, 70C:436-448.
57. Kosonen J., Kronberg L. The occurrence of antihistamines in sewage waters and in recipient rivers. Environ. Sci. Pollut. Res. Int. 2009, 16:555-564.
58. Kostich M.S., Batt A.L., Lazorchak J.M. Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation. Environ. Pollut. 2014, 184:354-359.
59. Kovalova L., Siegrist H., Singer H., Wittmer A., McArdell C.S. Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environ. Sci. Technol. 2012, 46:1536-1545.
60. Kwon J.W., Armbrust K.L. Aqueous solubility, n-octanol-water partition coefficient, and sorption of five selective serotonin reuptake inhibitors to sediments and soils. Bull. Environ. Contam. Toxicol. 2008, 81:128-135.
61. Lacey C., Basha S., Morrissey A., Tobin J.M. Occurrence of pharmaceutical compounds in wastewater process streams in Dublin, Ireland. Environ. Monit. Assess. 2012, 184:1049-1062.
62. Lambropoulou D.A., Nollet L.M.L. Transformation Products of Emerging Contaminants in the Environment 2014, 917-924. John Wiley and Sons Ltd.
63. Langford K.H., Thomas K.V. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environ. Int. 2009, 35:766-770.
64. Lapworth D.J., Baran N., Stuart M.E., Ward R.S. Emerging organic contaminants in groundwater: a review of sources, fate and occurrence. Environ. Pollut. 2012, 163:287-303.
65. Li B., Zhang T., Xu Z., Fang H.H. Rapid analysis of 21 antibiotics of multiple classes in municipal wastewater using ultra performance liquid chromatography-tandem mass spectrometry. Anal. Chim. Acta 2009, 645:64-72.
66. Loos R., Carvalho R., Antonio D.C., Comero S., Locoro G., Tavazzi S., et al. EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents. Water Res. 2013, 47:6475-6487.
67. López-Serna R., Pérez S., Ginebreda A., Petrović M., Barceló D. Fully automated determination of 74 pharmaceuticals in environmental and waste waters by online solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry. Talanta 2010, 83:410-424.
68. Luo Y., Guo W., Ngo H.H., Nghiem L.D., Hai F.I., Zhang J., et al. A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. Sci. Total Environ. 2014, 473-474:619-641.
69. Mahmood G., Mei Z., Hojjat H., Pace E., Kallakuri S., Zhang J.S. Therapeutic effect of sildenafil on blast-induced tinnitus and auditory impairment. Neuroscience 2014, 269:367-382.
70. Martin J., Buchberger W., Santos J.L., Alonso E., Aparicio I. High-performance liquid chromatography quadrupole time-of-flight mass spectrometry method for the analysis of antidiabetic drugs in aqueous environmental samples. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2012, 895-896:94-101.
71. Mead R.N., Barefoot S., Helms J.R., Morgan J.B., Kieber R.J. Photodegradation of the antihistamine cetirizine in natural waters. Environ. Toxicol. Chem. 2014, 33:2240-2245.
72. MHRA Serious liver damage associated with the food supplement Fortodol 2014.
73. Miao X.S., Bishay F., Chen M., Metcalfe C. D. Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. Environ. Sci. Technol. 2004, 38:3533-3541.
74. Moldovan Z. Occurrences of pharmaceutical and personal care products as micropollutants in rivers from Romania. Chemosphere 2006, 64:1808-1817.
75. Monsalvo V.M., McDonald J.A., Khan S.J., Le-Clech P. Removal of trace organics by anaerobic membrane bioreactors. Water Res. 2014, 49:103-112.
76. Moreno-Gonzalez R., Rodriguez-Mozaz S., Gros M., Barcelo D., Leon V.M. Seasonal distribution of pharmaceuticals in marine water and sediment from a Mediterranean coastal lagoon (SE Spain). Environ. Res. 2015, 138:326-344.
77. Nieto A., Peschka M., Borrull F., Pocurull E., Marce R.M., Knepper T.P. Phosphodiesterase type V inhibitors: occurrence and fate in wastewater and sewage sludge. Water Res. 2010, 44:1607-1615.
78. Ort C., Gujer W. Sampling for representative micropollutant loads in sewer systems. Water Sci. Technol. 2006, 54:169-176.
79. Ortiz de Garcia S., Pinto G.P., Garcia-Encina P.A., Irusta Mata R.I. Ranking of concern, based on environmental indexes, for pharmaceutical and personal care products: an application to the Spanish case. J. Environ. Manag. 2013, 129:384-397.
80. Park S., Choi K. Hazard assessment of commonly used agricultural antibiotics on aquatic ecosystems. Ecotoxicology 2008, 17:526-538.
81. Pereira A.M., Silva L.J., Meisel L.M., Lino C.M., Pena A. Environmental impact of pharmaceuticals from Portuguese wastewaters: geographical and seasonal occurrence, removal and risk assessment. Environ. Res. 2015, 136:108-119.
82. Petrie B., Barden R., Kasprzyk-Hordern B. A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring. Water Res. 2015, 72:3-27.
83. Petrovic M., Skrbic B., Zivancev J., Ferrando-Climent L., Barcelo D. Determination of 81 pharmaceutical drugs by high performance liquid chromatography coupled to mass spectrometry with hybrid triple quadrupole-linear ion trap in different types of water in Serbia. Sci. Total Environ. 2014, 468-469:415-428.
84. Radovic T., Grujic S., Petkovic A., Dimkic M., Lausevic M. Determination of pharmaceuticals and pesticides in river sediments and corresponding surface and ground water in the Danube River and tributaries in Serbia. Environ. Monit. Assess. 2015, 187:4092.
85. Ramaswamy B.R., Shanmugam G., Velu G., Rengarajan B., Larsson D.G. GC-MS analysis and ecotoxicological risk assessment of triclosan, carbamazepine and parabens in Indian rivers. J. Hazard. Mater. 2011, 186:1586-1593.
86. Rivera-Utrilla J., Sanchez-Polo M., Ferro-Garcia M.A., Prados-Joya G., Ocampo-Perez R. Pharmaceuticals as emerging contaminants and their removal from water. A review. Chemosphere 2013, 93:1268-1287.
87. Rodil R., Quintana J.B., Lopez-Mahia P., Muniategui-Lorenzo S., Prada-Rodriguez D. Multi-residue analytical method for the determination of emerging pollutants in water by solid-phase extraction and liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2009, 1216:2958-2969.
88. Rubirola A., Llorca M., Rodriguez-Mozaz S., Casas N., Rodriguez-Roda I., Barcelo D., et al. Characterization of metoprolol biodegradation and its transformation products generated in activated sludge batch experiments and in full scale WWTPs. Water Res. 2014, 63:21-32.
89. Salgado R., Noronha J.P., Oehmen A., Carvalho G., Reis M.A. Analysis of 65 pharmaceuticals and personal care products in 5 wastewater treatment plants in Portugal using a simplified analytical methodology. Water Sci. Technol. 2010, 62:2862-2871.
90. Samaras V.G., Stasinakis A.S., Mamais D., Thomaidis N.S., Lekkas T.D. Fate of selected pharmaceuticals and synthetic endocrine disrupting compounds during wastewater treatment and sludge anaerobic digestion. J. Hazard. Mater. 2013, 244-245:259-267.
91. Santos L.H., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., Barcelo D., et al. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci. Total Environ. 2013, 461-462:302-316.
92. Schultz M.M., Furlong E.T. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal. Chem. 2008, 80:1756-1762.
93. Schultz M.M., Furlong E.T., Kolpin D.W., Werner S.L., Schoenfuss H.L., Barber L.B., et al. Antidepressant pharmaceuticals in two U.S. effluent-impacted streams: occurrence and fate in water and sediment, and selective uptake in fish neural tissue. Environ. Sci. Technol. 2010, 44:1918-1925.
94. Schymanski E.L., Singer H.P., Longrée P., Loos M., Ruff M., Stravs M.A., et al. Strategies to characterize polar organic contamination in wastewater: exploring the capability of high resolution mass spectrometry. Environ. Sci. Technol. 2014, 48:1811-1818.
95. Sim W.J., Kim H.Y., Choi S.D., Kwon J.H., Oh J.E. Evaluation of pharmaceuticals and personal care products with emphasis on anthelmintics in human sanitary waste, sewage, hospital wastewater, livestock wastewater and receiving water. J. Hazard. Mater. 2013, 248-249:219-227.
96. Stamatis N.K., Konstantinou I.K. Occurrence and removal of emerging pharmaceutical, personal care compounds and caffeine tracer in municipal sewage treatment plant in Western Greece. J. Environ. Sci. Health B 2013, 48:800-813.
97. Stasinakis A.S., Mermigka S., Samaras V.G., Farmaki E., Thomaidis N.S. Occurrence of endocrine disrupters and selected pharmaceuticals in Aisonas River (Greece) and environmental risk assessment using hazard indexes. Environ. Sci. Pollut. Res. Int. 2012, 19:1574-1583.
98. Stasinakis A.S., Thomaidis N.S., Arvaniti O.S., Asimakopoulos A.G., Samaras V.G., Ajibola A., et al. Contribution of primary and secondary treatment on the removal of benzothiazoles, benzotriazoles, endocrine disruptors, pharmaceuticals and perfluorinated compounds in a sewage treatment plant. Sci. Total Environ. 2013, 463-464:1067-1075.
99. Stuer-Lauridsen F., Birkved M., Hansen L.P., Holten Lützhøft H.C., Halling-Sørensen B. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 2000, 40:783-793.
100. Stumpf M., Ternes T.A., Wilken R.-D., Silvana Vianna R., Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci. Total Environ. 1999, 225:135-141.
101. Subedi B., Kannan K. Occurrence and fate of select psychoactive pharmaceuticals and antihypertensives in two wastewater treatment plants in New York State, USA. Sci. Total Environ. 2015, 514:273-280.
102. Sun Q., Lv M., Hu A., Yang X., Yu C.P. Seasonal variation in the occurrence and removal of pharmaceuticals and personal care products in a wastewater treatment plant in Xiamen, China. J. Hazard. Mater. 2014, 277:69-75.
103. Valcárcel Y., Alonso S.G., Rodríguez-Gil J.L., Castaño A., Montero J.C., Criado-Alvarez J.J., et al. Seasonal variation of pharmaceutically active compounds in surface (Tagus River) and tap water (Central Spain). Environ. Sci. Pollut. Res. 2013, 20:1396-1412.
104. Van De Steene J.C., Stove C.P., Lambert W.E. A field study on 8 pharmaceuticals and 1 pesticide in Belgium: removal rates in waste water treatment plants and occurrence in surface water. Sci. Total. Environ. 2010, 408:3448-3453.
105. Vasskog T., Anderssen T., Pedersen-Bjergaard S., Kallenborn R., Jensen E. Occurrence of selective serotonin reuptake inhibitors in sewage and receiving waters at Spitsbergen and in Norway. J. Chromatogr. A 2008, 1185:194-205.
106. Verlicchi P., Galletti A., Petrovic M., Barceló D. Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J. Hydrol. 2010, 389:416-428.
107. Verlicchi P., Al Aukidy M., Galletti A., Petrovic M., Barcelo D. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci. Total Environ. 2012, 430:109-118.
108. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci. Total Environ. 2012, 429:123-155.
109. Vieno N.M., Härkki H., Tuhkanen T., Kronberg L. Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant. Environ. Sci. Technol. 2007, 41:5077-5084.
110. Yan Q., Gao X., Chen Y.P., Peng X.Y., Zhang Y.X., Gan X.M., et al. Occurrence, fate and ecotoxicological assessment of pharmaceutically active compounds in wastewater and sludge from wastewater treatment plants in Chongqing, the Three Gorges Reservoir area. Sci. Total Environ. 2014, 470-471:618-630.
111. Yang X., Flowers R.C., Weinberg H.S., Singer P.C. Occurrence and removal of pharmaceuticals and personal care products (PPCPs) in an advanced wastewater reclamation plant. Water. Res. 2011, 45:5218-5228.
112. Yu Y., Wu L., Chang A.C. Seasonal variation of endocrine disrupting compounds, pharmaceuticals and personal care products in wastewater treatment plants. Sci. Total Environ. 2013, 442:310-316.
113. Yuan S., Jiang X., Xia X., Zhang H., Zheng S. Detection, occurrence and fate of 22 psychiatric pharmaceuticals in psychiatric hospital and municipal wastewater treatment plants in Beijing, China. Chemosphere 2012.
114. Zorita S., Martensson L., Mathiasson L. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Sci. Total Environ. 2009, 407:2760-2770.
115. Zuehlke S., Duennbier U., Heberer T. Determination of Polar Drug Residues in Sewage and Surface Water Applying Liquid Chromatography-Tandem Mass Spectrometry. Anal. Chem. 2004, 76:6548-6554.